Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megadose CD34 Selected Progenitor Cells for Transplantation in Advanced Hematological Malignancies
NCT00038857Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2001
- Primary completion
- Jun 2009
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CD34-selected progenitor cells in leukemia, lymphoma, myelodysplastic syndrome (MDS), sponsored by University of Texas MD Anderson Cancer Center. Started Sep 2001; status: completed.
02
Drugs
CD34-selected progenitor cells
03
Conditions
leukemialymphomamyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00038857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038857.